Lynn-Allison Durham is the founder of STALICA, which is a biotech company focusing solely on Autism Spectrum Disorder (ASD). Using big data analytics, STALICLA is changing the paradigm in ASD drug development by bringing disease modifying and personalized medicine to patients with high unmet medical need.
